Skip to main content
Clinical Trials/NCT02014350
NCT02014350UnknownNot Applicable

Outcomes Following Delta Xtend Reverse Shoulder System

Rothman Institute Orthopaedics1 site in 1 countryStarted: December 18, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Locations
1
Primary Endpoint
Implant Survivorship

Study Overview

Brief Summary

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Implant Survivorship

Time Frame: 10 years post-operative

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials